Am. J. Respir. Cell Mol. Biol., Volume 21, Number 3, September, 1999 327-336

Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis

Yutaka Matsumoto, Koji Horiba, Jiro Usuki, Shan C. Chu, Victor J. Ferrans, and Joel Moss

Pulmonary-Critical Care Medicine Branch and Pathology Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland

Pulmonary lymphangioleiomyomatosis (LAM), a disease of young women, is characterized by proliferation of immature-appearing smooth-muscle cells (LAM cells) in the lungs and abdomen. LAM cells react with monoclonal antibody HMB45, which recognizes a 100-kD glycoprotein (gp100) originally found in human melanoma cells. We investigated the expression and the subcellular localization of gp100 in lung tissue from patients with LAM and in human melanoma cell lines (Malme-3M, A2058, and CHL-1), and the relationship between this expression and cellular proliferation. Binding sites for HMB45 antibody in melanoma and LAM cells were located in cytoplasmic granules resembling immature melanosomes. LAM cells reactive for proliferating-cell nuclear antigen (PCNA), a marker of cellular proliferation, were spindle-shaped, in contrast to the large, epithelioid cells reacting with HMB45 antibody. In accord with this finding, we observed an inverse relationship between the immunostaining for HMB45 antibody and PCNA in LAM and melanoma cells. Thus, LAM and melanoma cells are heterogeneous with respect to their stages of proliferation and their expression of melanoma antigens. PCNA-positive cells, which are more likely to be negative for reactivity with HMB45 antibody, may be more relevant to the progression of LAM than are HMB45-positive cells, which are the hallmark of LAM.

This article has been cited by other articles:

				C. G. GLASGOW, A. M. TAVEIRA-DASILVA, T. N. DARLING, and J. MOSS Lymphatic Involvement in Lymphangioleiomyomatosis Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 206 - 214. [Abstract] [Full Text] [PDF]

				S. C. Juvet, F. X. McCormack, D. J. Kwiatkowski, and G. P. Downey Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 398 - 408. [Abstract] [Full Text] [PDF]

				J. D'Armiento, K. Imai, J. Schiltz, N. Kolesnekova, D. Sternberg, K. Benson, A. Pardo, M. Selman, T. Smolarek, M. Vundavalli, et al. Identification of the Benign Mesenchymal Tumor Gene HMGA2 in Lymphangiomyomatosis Cancer Res., March 1, 2007; 67(5): 1902 - 1909. [Abstract] [Full Text] [PDF]

				J. C. Valencia, G. Pacheco-Rodriguez, A. K. Carmona, J. Xavier, P. Bruneval, W. K. Riemenschneider, Y. Ikeda, Z.-X. Yu, V. J. Ferrans, and J. Moss Tissue-Specific Renin-Angiotensin System in Pulmonary Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 40 - 47. [Abstract] [Full Text] [PDF]

				S. R. Johnson Lymphangioleiomyomatosis. Eur. Respir. J., May 1, 2006; 27(5): 1056 - 1065. [Abstract] [Full Text] [PDF]

				J. L. Black, Q. Ge, S. Boustany, P. R. A. Johnson, M. H. Poniris, A. R. Glanville, B. G. G. Oliver, L. M. Moir, and J. K. Burgess In vitro studies of lymphangioleiomyomatosis Eur. Respir. J., October 1, 2005; 26(4): 569 - 576. [Abstract] [Full Text] [PDF]

				N. El-Hashemite, V. Walker, and D. J. Kwiatkowski Estrogen Enhances whereas Tamoxifen Retards Development of Tsc Mouse Liver Hemangioma: A Tumor Related to Renal Angiomyolipoma and Pulmonary Lymphangioleiomyomatosis Cancer Res., March 15, 2005; 65(6): 2474 - 2481. [Abstract] [Full Text] [PDF]

				E. Battistini, C. Gambini, U. G. Rossi, L. Fazio, U. Catrambone, G. Pittaluga, P. Toma, and G. A. Rossi Spontaneous pneumothorax in a 24-year-old female Eur. Respir. J., March 1, 2005; 25(3): 575 - 580. [Full Text] [PDF]

				D. M. Crooks, G. Pacheco-Rodriguez, R. M. DeCastro, J. P. McCoy Jr., J.-a. Wang, F. Kumaki, T. Darling, and J. Moss Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis PNAS, December 14, 2004; 101(50): 17462 - 17467. [Abstract] [Full Text] [PDF]

				X. Zhe and L. Schuger Combined Smooth Muscle and Melanocytic Differentiation in Lymphangioleiomyomatosis J. Histochem. Cytochem., December 1, 2004; 52(12): 1537 - 1542. [Abstract] [Full Text] [PDF]

				G. Finlay The LAM cell: what is it, where does it come from, and why does it grow? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L690 - L693. [Full Text] [PDF]

				S. E. Evans, T. V. Colby, J. H. Ryu, and A. H. Limper Transforming Growth Factor-{beta}1 and Extracellular Matrix-Associated Fibronectin Expression in Pulmonary Lymphangioleiomyomatosis Chest, March 1, 2004; 125(3): 1063 - 1070. [Abstract] [Full Text] [PDF]

				E. A. Goncharova, D. A. Goncharov, A. Eszterhas, D. S. Hunter, M. K. Glassberg, R. S. Yeung, C. L. Walker, D. Noonan, D. J. Kwiatkowski, M. M. Chou, et al. Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation. A ROLE FOR THE TSC2 TUMOR SUPPRESSOR GENE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS (LAM) J. Biol. Chem., August 16, 2002; 277(34): 30958 - 30967. [Abstract] [Full Text] [PDF]

				K. Matsui, W. D. Travis, R. Gonzalez, J. A. Terzian, J. Rosai, J. Moss, and V. J. Ferrans Association of Lymphangioleiomyomatosis (LAM) with Endosalpingiosis in the Retroperitoneal Lymph Nodes: Report of Two Cases International Journal of Surgical Pathology, April 1, 2001; 9(2): 155 - 162. [Abstract] [PDF]